Search

Your search keyword '"JIE YU"' showing total 48 results

Search Constraints

Start Over You searched for: Author "JIE YU" Remove constraint Author: "JIE YU" Journal blood Remove constraint Journal: blood
48 results on '"JIE YU"'

Search Results

3. Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation

4. Effect of Dasatinib Vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized, Open-Label, Multicenter Study of the Chinese Children's Cancer Group

5. Septicemia after Chemotherapy for Acute Lymphoblastic Leukemia: A Multicenter Study Chinese Children Cancer Group (CCCG)-ALL-2015

6. Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma

7. ARRB1-Induced NOTCH1 Degradation Is Inhibited By Mir-223 in T-ALL

8. Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells

9. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma

12. The Anti-Tumor Effect of the Ubiquitin-Activating Enzyme (UAE) Inhibitor TAK-243 on Pre-Clinical Models of Multiple Myeloma

13. PDGFR Inhibitor Imatinib May be a Potent Drug in Treating Essential Thrombocythemia

14. The Syk Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of EBV-Associated Lymphoma

15. Aberrant Let7a/HMGA2 Signaling Axis with Unique Clinical Phenotype in JAK2-Mutated Myeloproliferative Neoplasms

16. Response to Prednisone Window Treatment Is a Universal Early Prognostic Marker in Chinese Children with T Lineage ALL Despite Outcome Disparity: A Multi-Center Experience

17. Ninlaro (ixazomib) and Brentuximab Vedotin (ADCETRIS) Combination Results in Synergistic Antitumor Activity in Mouse Models of CD30 Positive Anaplastic Large Cell Lymphoma

21. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells

22. Favorable Clinical Outcome and Unique Characteristics in Association with Twist1 overexpression in De Novo Acute Myeloid Leukemia

23. The Regulation of β-arrestin1 in Leukemia Initiating Cells of Children B-Acute Lymphoblastic Leukemia

31. Preclinical Combination Of The Oral Investigational Agents ACY-1215, a Selective HDAC6 Inhibitor, and Ixazomib, a Proteasome Inhibitor, Demonstrates Combination Benefit In Multiple Myeloma Cell Lines and Xenograft Models

32. TPO exerts a protective effect on iron-overload induces apoptosis in cardiomyocytes via mitochondrial pathways

33. TPO plus Tanshinone IIA has neural protective effect and this effect may be mediated via its receptor c-mpl and PI3K/Akt signaling

42. In-Vitro and in-Vivo Evaluation of the Orally Active Proteasome Inhibitor MLN9708 in Hematological Models of Human Cancer

44. MLN4924, a Novel Small Molecule Inhibitor of Nedd8-Activating Enzyme, Demonstrates Potent Anti-Tumor Activity in Diffuse Large B-Cell Lymphoma

45. Cocktail Therapy Increased the Survival Rate of APL

46. Aberrant Let7a/HMGA2Signaling Axis with Unique Clinical Phenotype in JAK2-Mutated Myeloproliferative Neoplasms

47. Favorable Clinical Outcome and Unique Characteristics in Association with Twist1overexpression in De NovoAcute Myeloid Leukemia

Catalog

Books, media, physical & digital resources